The third is that while SLE patients are reported to have increased adipose tissue (39, 40), which could be a consequence of clinical treatment using glucocorticoid, precise molecular mechanisms underlying leptin production and LepR deficiency in SLE patients remain unclear. Here, LEPR is linked to systemic lupus erythematosus.